Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan 12:338:a3006.
doi: 10.1136/bmj.a3006.

Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review

Despina G Contopoulos-Ioannidis  1 , Anastasia Karvouni, Ioanna Kouri, John P A Ioannidis
Affiliations

Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review

Despina G Contopoulos-Ioannidis et al. BMJ. .

Abstract

Objective: To determine how often health surveys and quality of life evaluations reach different conclusions from those of primary efficacy outcomes and whether discordant results make a difference in the interpretation of trial findings.

Design: Systematic review.

Data sources: PubMed, contact with authors for missing information, and author survey for unpublished SF-36 data.

Study selection: Randomised trials with SF-36 outcomes (the most extensively validated and used health survey instrument for appraising quality of life) that were published in 2005 in 22 journals with a high impact factor.

Data extraction: Analyses on the two composite and eight subdomain SF-36 scores that corresponded to the time and mode of analysis of the primary efficacy outcome.

Results: Of 1057 screened trials, 52 were identified as randomised trials with SF-36 results (66 separate comparisons). Only eight trials reported all 10 SF-36 scores in the published articles. For 21 of the 66 comparisons, SF-36 results were discordant for statistical significance compared with the results for primary efficacy outcomes. Of 17 statistically significant SF-36 scores where primary outcomes were not also statistically significant in the same direction, the magnitude of effect was small in six, moderate in six, large in three, and not reported in two. Authors modified the interpretation of study findings based on SF-36 results in only two of the 21 discordant cases. Among 100 additional randomly selected trials not reporting any SF-36 information, at least five had collected SF-36 data but only one had analysed it.

Conclusions: SF-36 measurements sometimes produce different results from those of the primary efficacy outcomes but rarely modify the overall interpretation of randomised trials. Quality of life and health related survey information should be utilised more systematically in randomised trials.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

None
Flow chart of papers through trial
See this image and copyright information in PMC

Comment in

References

    1. Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ. Users’ guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. JAMA 1997;277:1232-7. - PubMed
    1. Sanders C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ 1998;317:1191-4. - PMC - PubMed
    1. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R. Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the UK Medical Research Council experience. MRC Cancer Trials Office. Eur J Cancer 1997;33:20-8. - PubMed
    1. Food and Drug Administration. Draft guidance for industry on patient-reported outcome measures: use in medicinal product development to support labeling claims. Fed Register 2006;71:5862-3.
    1. Committee for Medicinal Products for Human Use. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. www.emea.europa.eu/pdfs/human/ewp/1393104en.pdf. 2005.

Publication types

LinkOut - more resources